Important industry news and company updates
Clinical trials for rare diseases
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 14.Dec.2015
Clinical trials registry eliminates any risks of possible selective reporting

When we compare clinical trials for rare diseases and clinical trials for non-rare diseases we can see that the participation of people in the first type has been said to be extremely low. A recent survey shows that out of 24,088 clinical trials, 2,759 (11, 5 %) of them were defined as rare disease trials in which under 50 individuals are indicated to demonstrate interest in taking part in one of them. In this regard, recruiters experience major difficulties in...MORE >

Top universities in Pharmacology and Pharmacy
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 11.Dec.2015
Top universities in Pharmacology and Pharmacy

It is not a secret that clinical research is an industry providing many people with opportunities to have a regional or international career. It is not only a great place to earn a good to high salary, but you can also travel a lot, work towards people’s good fortune and be able to move around different departments and get different experience. Unlike doctor’s profession it is rare clinical research professionals deal directly with patients, which can be sometimes really stressful...MORE >

Adaptive Clinical Trials: Advanced ways to more adequate results
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 09.Dec.2015
Adaptive Clinical Trials

It takes time, a lot of recourses and substantial research to develop a new drug that is effective and serves a medical purpose. Nevertheless, it has been indicated that not always the process of researching leads to positive and productive outcomes, which becomes a major setback in the Pharmaceutical industry. In order to avoid such drawbacks that prevent the industry from quicker progress, regulators and researchers try to find more advanced ways that will lead to more adequate results. Realizing...MORE >

Valuable Strategies for Successful Globalization of Clinical Trials
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 08.Dec.2015
Valuable Strategies for Successful Globalization of Clinical Trials

We can’t deny the fact that according to modern-day equations and measurements, corporate value is equal to the number of external people (users, investors, sponsors etc.) attracted to the service or products being provided. To present it differently, the more sides are involved, the wider impact the business is said to have. In order businesses to be highly effective and more encompassing, they need to reach as many people and parts of the world as possible. It is called globalization...MORE >

The benefits of crowdfunding for clinical trials
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 04.Dec.2015

Sponsoring clinical trials is integral but not an easy task to do. With the lack of enough resources, researchers are looking for alternatives which will help them reach to a bigger group of people that can help them financially. Their help is important as absence of resources quite often is the reason for a trial failure. In order to fight this sort of difficulties and challenges that stand between the start and the end of clinical projects, researchers are constantly...MORE >

A Two-by-two Trial Design and Behavior-treatment interaction
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 03.Dec.2015
A Two-by-two Trial Design and Behavior-treatment interaction

Usually double-blind randomized controlled trials (DBRCTs) are considered to be the gold standard when it comes to eliminating any patient or doctor bias. However, recent studies have pointed out that if researchers want to receive 100% efficacy without results being affected by other factors, the double-blind randomized controlled studies might not be the best choice. Consequently, experts have suggested a much better approach to assessing and conducting various clinical processes. The approach in question is a new study outline that...MORE >

Online Training vs In-house Training: Which is better?
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 02.Dec.2015
Online Training vs In-house Training Which is better

Learning is part of the dynamics of our everydayness and it has a major impact on our personal or professional life. People sign up for various courses and trainings in order to acquire new skills, enhance or reinforce what they already know and polish what they are not so familiar with. Such educational programs are no exception for the Pharmaceutical and Clinical industry. In this regard, the more experienced and knowledgeable sponsors and researchers are, the smoother all the processes...MORE >

The Principles of Good Distribution Practices
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 01.Dec.2015
The Principles of Good Distribution Practices

Good Distribution Practices or also known as GDP is the official guideline delivered by the World Health Organization to serve as the standards for transporting and distributing pharmaceutical products in order to maintain their high quality and safety. It is a part of the GxP series of regulations (for example Good Clinical Practice, Good Laboratory Practice, Good Manufacturing Practice etc.) which are there to ensure that people using the final pharmaceutical products will be safe. Who needs to comply with the Good...MORE >

13 core principles of ICH-GCP
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 30.Nov.2015
Principles of ICH-GCP

When we talk about medical or clinical research, Good Clinical Practice is usually referred to the pivotal idea of compliance with certain regulations, guidelines, rules and laws which serve to ensure quality of data and guarantee for the well-being of the participants in a specific trial. In order to outline the importance of ICH-GCP, here we are listing 13 core principles: 1. Conduct trials according to: Ethical principles from DoH, Consistent with GCP Applicable regulatory requirement(s) 2. Before initiating, weigh risks against benefit (participant and...MORE >

How to extrapolate Good Clinical Practice inspection findings?
  • Share
  • Facebook
  • Twitter
  • Google +
  • Linkedin
Published - 27.Nov.2015
How to extrapolate GCP inspection findings

Good Clinical Practice is a set of internationally recognised ethical and scientific quality requirements which must be observed for designing, conducting, recording and reporting clinical trials that involve the participation of human subjects. Compliance with this good practice provides assurance that the rights, safety and well-being of trial subjects are protected, and that the results of the clinical trials are credible (EU Directive 2001/20/EC in Article 1 (Scope)).  When inspectors identify non-compliance at a particular investigational site with potential impact on...MORE >

Join our 15,420 Users!
Get FREE advice and suggestions on how to improve your medical career with our regular email newsletter.
Sign up NOW

Copyright © 2018, AstraNova Ltd. All Rights Reserved. DMCA.com